1. Fazekas F, Kleinert R, Roob G, Kleinert G, Kapeller P, Schmidt R, et al. Histopathologic analysis of foci of signal loss on gradient-echo T2*-weighted MR images in patients with spontaneous intracerebral hemorrhage: evidence of microangiopathy-related microbleeds.
AJNR Am J Neuroradiol. 1999;20:637-642.
2. Mittal S, Wu Z, Neelavalli J, Haacke EM. Susceptibility-weighted imaging: technical aspects and clinical applications, part 2.
AJNR Am J Neuroradiol. 2009;30:232-252.
3. Cheng AL, Batool S, McCreary CR, Lauzon ML, Frayne R, Goyal M, et al. Susceptibility-weighted imaging is more reliable than T2*-weighted gradient-recalled echo MRI for detecting microbleeds.
Stroke. 2013;44:2782-2786.
4. Tsushima Y, Tanizaki Y, Aoki J, Endo K. MR detection of microhemorrhages in neurologically healthy adults.
Neuroradiology. 2002;44:31-36.
5. Vernooij MW, van der Lugt A, Ikram MA, Wielopolski PA, Niessen WJ, Hofman A, et al. Prevalence and risk factors of cerebral microbleeds: the Rotterdam scan study.
Neurology. 2008;70:1208-1214.
6. Romero JR, Preis SR, Beiser A, DeCarli C, Viswanathan A, Martinez-Ramirez S, et al. Risk factors, stroke prevention treatments, and prevalence of cerebral microbleeds in the Framingham heart study.
Stroke. 2014;45:1492-1494.
7. Graff-Radford J, Simino J, Kantarci K, Mosley TH Jr, Griswold ME, Windham BG, et al. Neuroimaging correlates of cerebral microbleeds: the ARIC study (Atherosclerosis Risk in Communities).
Stroke. 2017;48:2964-2972.
8. Ding J, Sigurðsson S, Jónsson PV, Eiriksdottir G, Meirelles O, Kjartansson O, et al. Space and location of cerebral microbleeds, cognitive decline, and dementia in the community.
Neurology. 2017;88:2089-2097.
9. Tanaka A, Ueno Y, Nakayama Y, Takano K, Takebayashi S. Small chronic hemorrhages and ischemic lesions in association with spontaneous intracerebral hematomas.
Stroke. 1999;30:1637-1642.
10. Yates PA, Villemagne VL, Ellis KA, Desmond PM, Masters CL, Rowe CC. Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations.
Front Neurol. 2014;4:205.
11. Azad R, Mittal P, Malhotra A, Gangrade S. Detection and differentiation of focal intracranial calcifications and chronic microbleeds using MRI.
J Clin Diagn Res. 2017;11:TC19-TC23.
12. Haller S, Montandon ML, Lazeyras F, Scheffler M, Meckel S, Herrmann FR, et al. Radiologic-histopathologic correlation of cerebral microbleeds using pre-mortem and post-mortem MRI.
PLoS One. 2016;11:e0167743.
13. Charidimou A, Kakar P, Fox Z, Werring DJ. Cerebral microbleeds and recurrent stroke risk: systematic review and meta-analysis of prospective ischemic stroke and transient ischemic attack cohorts.
Stroke. 2013;44:995-1001.
14. Charidimou A, Shams S, Romero JR, Ding J, Veltkamp R, Horstmann S, et al. Clinical significance of cerebral microbleeds on MRI: a comprehensive meta-analysis of risk of intracerebral hemorrhage, ischemic stroke, mortality, and dementia in cohort studies (v1).
Int J Stroke. 2018;13:454-468.
15. Charidimou A, Imaizumi T, Moulin S, Biffi A, Samarasekera N, Yakushiji Y, et al. Brain hemorrhage recurrence, small vessel disease type, and cerebral microbleeds: a meta-analysis.
Neurology. 2017;89:820-829.
16. Charidimou A, Karayiannis C, Song TJ, Orken DN, Thijs V, Lemmens R, et al. Brain microbleeds, anticoagulation, and hemorrhage risk: meta-analysis in stroke patients with AF.
Neurology. 2017;89:2317-2326.
17. Katsanos AH, Mavridis D, Parissis J, Deftereos S, Frogoudaki A, Vrettou AR, et al. Novel oral anticoagulants for the secondary prevention of cerebral ischemia: a network meta-analysis.
Ther Adv Neurol Disord. 2016;9:359-368.
18. Tsivgoulis G, Lioutas VA, Varelas P, Katsanos AH, Goyal N, Mikulik R, et al. Direct oral anticoagulant- vs vitamin K antagonist-related nontraumatic intracerebral hemorrhage.
Neurology. 2017;89:1142-1151.
19. Saito T, Kawamura Y, Sato N, Kano K, Takahashi K, Asanome A, et al. Non-vitamin K antagonist oral anticoagulants do not increase cerebral microbleeds.
J Stroke Cerebrovasc Dis. 2015;24:1373-1377.
20. Tsivgoulis G, Kargiotis O, Alexandrov AV. Intravenous thrombolysis for acute ischemic stroke: a bridge between two centuries.
Expert Rev Neurother. 2017;17:819-837.
21. Tsivgoulis G, Zand R, Katsanos AH, Turc G, Nolte CH, Jung S, et al. Risk of symptomatic intracerebral hemorrhage after intravenous thrombolysis in patients with acute ischemic stroke and high cerebral microbleed burden: a meta-analysis.
JAMA Neurol. 2016;73:675-683.
22. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association.
Stroke. 2018;49:e46-e110.
23. Knudsen KA, Rosand J, Karluk D, Greenberg SM. Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria.
Neurology. 2001;56:537-539.
24. Gregg NM, Kim AE, Gurol ME, Lopez OL, Aizenstein HJ, Price JC, et al. Incidental cerebral microbleeds and cerebral blood flow in elderly individuals.
JAMA Neurol. 2015;72:1021-1028.
25. Chen YW, Lee MJ, Smith EE. Cerebral amyloid angiopathy in East and West.
Int J Stroke. 2010;5:403-411.
26. Miller-Thomas MM, Sipe AL, Benzinger TL, McConathy J, Connolly S, Schwetye KE. Multimodality review of amyloid-related diseases of the central nervous system.
Radiographics. 2016;36:1147-1163.
27. Auriel E, Charidimou A, Gurol ME, Ni J, Van Etten ES, Martinez-Ramirez S, et al. Validation of clinicoradiological criteria for the diagnosis of cerebral amyloid angiopathy-related inflammation.
JAMA Neurol. 2016;73:197-202.
28. Lee SH, Park JM, Kwon SJ, Kim H, Kim YH, Roh JK, et al. Left ventricular hypertrophy is associated with cerebral microbleeds in hypertensive patients.
Neurology. 2004;63:16-21.
29. Schrag M, Greer DM. Clinical associations of cerebral microbleeds on magnetic resonance neuroimaging.
J Stroke Cerebrovasc Dis. 2014;23:2489-2497.
30. Gungor I, Sarro L, Graff-Radford L, Zuk SM, Tosakulwong N, Przybelski SA, et al. Frequency and topography of cerebral microbleeds in dementia with Lewy bodies compared to Alzheimer’s disease.
Parkinsonism Relat Disord. 2015;21:1101-1104.
31. Scheid R, Walther K, Guthke T, Preul C, von Cramon DY. Cognitive sequelae of diffuse axonal injury.
Arch Neurol. 2006;63:418-424.
32. Bousser M, Tournier-Lasserve E. Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy: from stroke to vessel wall physiology.
J Neurol Neurosurg Psychiatry. 2001;70:285-287.
33. Stojanov D, Vojinovic S, Aracki-Trenkic A, Tasic A, Benedeto-Stojanov D, Ljubisavljevic S, et al. Imaging characteristics of cerebral autosomal dominant arteriopathy with subcortical infarcts and leucoencephalopathy (CADASIL).
Bosn J Basic Med Sci. 2015;15:1-8.
34. Lesnik Oberstein SA, van den Boom R, van Buchem MA, van Houwelingen HC, Bakker E, Vollebregt E, et al. Cerebral microbleeds in CADASIL.
Neurology. 2001;57:1066-1070.
35. Dichgans M, Holtmannspötter M, Herzog J, Peters N, Bergmann M, Yousry TA. Cerebral microbleeds in CADASIL: a gradient-echo magnetic resonance imaging and autopsy study.
Stroke. 2002;33:67-71.
36. Lee JS, Ko K, Oh JH, Park JH, Lee HK, Floriolli D, et al. Cerebral microbleeds, hypertension, and intracerebral hemorrhage in cerebral autosomal-dominant arteriopathy with subcortical infarcts and leukoencephalopathy.
Front Neurol. 2017;8:203.
37. Nannucci S, Rinnoci V, Pracucci G, MacKinnon AD, Pescini F, Adib-Samii P, et al. Location, number and factors associated with cerebral microbleeds in an Italian-British cohort of CADASIL patients.
PLoS One. 2018;13:e0190878.
39. Reisin RC, Romero C, Marchesoni C, Nápoli G, Kisinovsky I, Cáceres G, et al. Brain MRI findings in patients with Fabry disease.
J Neurol Sci. 2011;305:41-44.
40. Kono Y, Wakabayashi T, Kobayashi M, Ohashi T, Eto Y, Ida H, et al. Characteristics of cerebral microbleeds in patients with Fabry disease.
J Stroke Cerebrovasc Dis. 2016;25:1320-1325.
41. Gould DB, Phalan FC, van Mil SE, Sundberg JP, Vahedi K, Massin P, et al. Role of COL4A1 in small-vessel disease and hemorrhagic stroke.
N Engl J Med. 2006;354:1489-1496.
42. Weng YC, Sonni A, Labelle-Dumais C, de Leau M, Kauffman WB, Jeanne M, et al. COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage.
Ann Neurol. 2012;71:470-477.
43. Lanfranconi S, Markus HS. COL4A1 mutations as a monogenic cause of cerebral small vessel disease: a systematic review.
Stroke. 2010;41:e513-e518.
47. McKinney AM, Sarikaya B, Gustafson C, Truwit CL. Detection of microhemorrhage in posterior reversible encephalopathy syndrome using susceptibility-weighted imaging.
AJNR Am J Neuroradiol. 2012;33:896-903.
48. Baddour LM, Wilson WR, Bayer AS, Fowler VG Jr, Tleyjeh IM, Rybak MJ, et al. Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association.
Circulation. 2015;132:1435-1486.
49. Klein I, Iung B, Labreuche J, Hess A, Wolff M, Messika-Zeitoun D, et al. Cerebral microbleeds are frequent in infective endocarditis: a case-control study.
Stroke. 2009;40:3461-3465.
50. Okazaki S, Sakaguchi M, Hyun B, Nagano K, Tagaya M, Sakata Y, et al. Cerebral microbleeds predict impending intracranial hemorrhage in infective endocarditis.
Cerebrovasc Dis. 2011;32:483-488.
51. Hess A, Klein I, Iung B, Lavallée P, Ilic-Habensus E, Dornic Q, et al. Brain MRI findings in neurologically asymptomatic patients with infective endocarditis.
AJNR Am J Neuroradiol. 2013;34:1579-1584.
52. Iung B, Tubiana S, Klein I, Messika-Zeitoun D, Brochet E, Lepage L, et al. Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study.
Stroke. 2013;44:3056-3062.
54. Kikuta K, Takagi Y, Nozaki K, Sawamoto N, Fukuyama H, Hashimoto N. The presence of multiple microbleeds as a predictor of subsequent cerebral hemorrhage in patients with moyamoya disease.
Neurosurgery. 2008;62:104-111.
55. Sun W, Yuan C, Liu W, Li Y, Huang Z, Zhu W, et al. Asymptomatic cerebral microbleeds in adult patients with moyamoya disease: a prospective cohort study with 2 years of follow-up.
Cerebrovasc Dis. 2013;35:469-475.
56. Wenz H, Wenz R, Maros M, Ehrlich G, Al-Zghloul M, Groden C, et al. Incidence, locations, and longitudinal course of cerebral microbleeds in European moyamoya.
Stroke. 2017;48:307-313.
57. Rabin BM, Meyer JR, Berlin JW, Marymount MH, Palka PS, Russell EJ. Radiation-induced changes in the central nervous system and head and neck.
Radiographics. 1996;16:1055-1072.
58. Tanino T, Kanasaki Y, Tahara T, Michimoto K, Kodani K, Kakite S, et al. Radiation-induced microbleeds after cranial irradiation: evaluation by phase-sensitive magnetic resonance imaging with 3.0 tesla.
Yonago Acta Med. 2013;56:7-12.
59. Lupo JM, Molinaro AM, Essock-Burns E, Butowski N, Chang SM, Cha S, et al. The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma.
Neuro Oncol. 2016;18:87-95.
60. Shen Q, Lin F, Rong X, Yang W, Li Y, Cai Z, et al. Temporal cerebral microbleeds are associated with radiation necrosis and cognitive dysfunction in patients treated for nasopharyngeal carcinoma.
Int J Radiat Oncol Biol Phys. 2016;94:1113-1120.
63. Song TJ, Park JH, Choi KH, Chang Y, Moon J, Kim JH, et al. Moderate-to-severe obstructive sleep apnea is associated with cerebral small vessel disease.
Sleep Med. 2017;30:36-42.
64. Koo DL, Kim JY, Lim JS, Kwon HM, Nam H. Cerebral microbleeds on MRI in patients with obstructive sleep apnea.
J Clin Sleep Med. 2017;13:65-72.
65. Treadwell SD, Robinson TG. Cocaine use and stroke.
Postgrad Med J. 2007;83:389-394.
66. Shoamanesh A, Catanese L, Romero JR, Lau H, Babikian VL, Benavente OR, et al. High prevalence of cerebral microbleeds in inner city young stroke patients.
J Stroke Cerebrovasc Dis. 2016;25:733-738.
67. Rutgers DR, Saliou G, Ducreux D. Microbleeds in thrombotic thrombocytopenic purpura.
J Neuroradiol. 2008;35:187-188.
68. Noorbakhsh-Sabet N, Zand R. Thrombotic thrombocytopenic purpura with concomitant progressive cerebral microbleeds.
J Stroke Cerebrovasc Dis. 2016;25:e214-e215.
69. Wijdicks EF, Silbert PL, Jack CR, Parisi JE. Subcortical hemorrhage in disseminated intravascular coagulation associated with sepsis.
AJNR Am J Neuroradiol. 1994;15:763-765.
70. Neligan A, Rajakulendran S, Nortley R, Manji H. Extensive cerebral microhemorrhages caused by acute disseminated intravascular coagulation secondary to sepsis.
JAMA Neurol. 2014;71:510-511.
71. Trevino-Peinado C, Zubieta JL, Fernández MM. Subcortical microbleeds in disseminated intravascular coagulation mimicking amyloid angiopathy.
J Neuroimaging. 2015;25:660-661.
72. DeBakey ME, Henly WS, Cooley DA, Morris GC Jr, Crawford ES, Beall AC Jr. Surgical management of dissecting aneurysms of the aorta.
J Thorac Cardiovasc Surg. 1965;49:130-149.
73. Nakamura S, Misumi I, Koide S. Cholesterol embolism as a complication of aortic dissection.
Circulation. 1999;100:e48-e50.
74. Braem L, Paule P, Héno P, Morand JJ, Mafart B, La Folie T, et al. Thoracic aortic dissection revealed by systemic cholesterol embolism.
Ann Cardiol Angeiol (Paris). 2006;55:300-303.
75. Müller C, Rahn BA, Pfister U, Meinig RP. The incidence, pathogenesis, diagnosis, and treatment of fat embolism.
Orthop Rev. 1994;23:107-117.
76. Kamenar E, Burger PC. Cerebral fat embolism: a neuropathological study of a microembolic state.
Stroke. 1980;11:477-484.
77. Lee J. Gradient-echo MRI in defining the severity of cerebral fat embolism.
J Clin Neurol. 2008;4:164-166.
78. Mossa-Basha M, Izbudak I, Gurda GT, Aygun N. Cerebral fat embolism syndrome in sickle cell anaemia/β-thalassemia: importance of susceptibility-weighted MRI.
Clin Radiol. 2012;67:1023-1026.
79. Haller S, Vernooij MW, Kuijer JPA, Larsson EM, Jäger HR, Barkhof F. Cerebral microbleeds: imaging and clinical significance.
Radiology. 2018;287:11-28.
80. Renard D. Cerebral microbleeds: a magnetic resonance imaging review of common and less common causes.
Eur J Neurol. 2018;25:441-450.